Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.50
+0.16004.79%
Post-market: 3.500.00000.00%19:59 EDT
Volume:22.90M
Turnover:80.71M
Market Cap:1.87B
PE:-3.42
High:3.63
Open:3.39
Low:3.37
Close:3.34
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:1.28
T/O Rate:4.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.05
PE(LYR):-2.43

Loading ...

Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Lose Momentum In Recent Months

Simply Wall St.
·
May 24

Nvidia-Linked Shares Rally. Applied Digital up 18%; NEBIUS up 17%; WhiteFiber up 13%; ARM Holdings, Lumentum up 9% Each; CoreWeave up Nearly 5%

Tiger Newspress
·
May 21

Recursion Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 15

Stock Track | Recursion Pharmaceuticals Soars 5.08% Intraday After Morgan Stanley Raises Price Target

Stock Track
·
May 14

Morgan Stanley Raises Price Target on Recursion Pharmaceuticals to $5.50 From $5, Keeps Equalweight Rating

MT Newswires Live
·
May 14

Recursion director Christopher Gibson disposes of 60,000 shares for $134,800

Reuters
·
May 09

Recursion director Blake Borgeson disposes 30,000 shares for $105,600

Reuters
·
May 08

Recursion Pharmaceuticals Price Target Maintained With a $8.00/Share by Needham

Dow Jones
·
May 07

Recursion Pharmaceuticals (RXRX) Receives a Hold from Bank of America Securities

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: Kissei Pharmaceutical Co (OtherKSPHF), Recursion Pharmaceuticals (RXRX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 07

Wall Street Analysts Are Neutral on Top Healthcare Picks

TIPRANKS
·
May 07

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber

Reuters
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-AMD, Apollo, Deckers Outdoor

Reuters
·
May 06

BUZZ-Recursion falls after quarterly revenue miss

Reuters
·
May 06

Recursion Pharmaceuticals Shares Dip 3% Premarket After Q1 Results

THOMSON REUTERS
·
May 06

Recursion Pharmaceuticals misses Q1 operating revenue estimates, net loss narrows

Reuters
·
May 06

Recursion Pharmaceuticals Q1 EPS $(0.22) Beats $(0.27) Estimate, Sales $6.472M Miss $15.777M Estimate

Benzinga Earnings
·
May 06

BRIEF-Recursion Pharmaceuticals Q1 Operating Revenue USD 6.301 Million Vs. IBES Estimate USD 15.8 Million

Reuters
·
May 06

Recursion Pharmaceuticals Q1 Operating Income USD -128.505 Million

THOMSON REUTERS
·
May 06

Recursion Reports First Quarter Financial Results and Provides Business Update

GlobeNewswire
·
May 06